Experimental models of atherosclerosis;Modelos experimentales de aterosclerosis

Revista Espanola de Cardiologia Suplementos

Volumn 13, Issue 5, 2013, Pages 3-12

  Santos Gallego, Carlos G ^a   Badimon, Juan J ^a   Ibáñez, Borja ^b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Animal model; Atherosclerosis; Genetically modification; Hypercholesterolemia

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; COST BENEFIT ANALYSIS; DISEASE MODEL; DNA MODIFICATION; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; HUMAN VERSUS ANIMAL COMPARISON; IMAGING; MEDICAL RESEARCH; NON INVASIVE PROCEDURE; NONHUMAN; PATHOLOGICAL ANATOMY;

EID: 84887914637     PISSN: 11313587     EISSN: 15792250     Source Type: Journal    
DOI: 10.1016/S1131-3587(13)70087-6     Document Type: Article

References (70)

1. Ignatowski A.C. Influence of animal foods and the study of atherosclerosis on the organism of rabbits. S Peterb Izviest Imp Voyenoo-Med Akad 1908, 16:154-173.
2. Anitschow A. Über Veränderungen der Kaninchen-Aorta bei Experimenteller Cholesterinsteatose. Beitr Z Path Anat U Z Allag Path 1913, 56:379-384.
3. Wissler R.W. The production of atheromatous lesions in the albino rat. Proc Inst Med Chic 1952, 19:79-80.
4. Paigen B., Morrow A., Brandon C., Mitchell D., Holmes P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 1985, 57:65-73.
5. Paigen B., Havens M.B., Morrow A. Effect of 3-methylcholanthrene on the development of aortic lesions in mice. Cancer Res 1985, 45:3850-3855.
6. Getz G.S., Reardon C.A. Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26:242-249.
7. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353.
8. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
9. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994, 14:133-140.
10. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993, 92:883-893.
11. Meir K.S., Leitersdorf E. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 2004, 24:1006-1014.
12. Catanozi S., Rocha J.C., Passarelli M., Chiquito F.C., Quintao E.C., Nakandakare E.R. Pitfalls in the assessment of murine atherosclerosis. Braz J Med Biol Res 2009, 42:471-475.
13. Nikkari S.T., Solakivi T., Jaakkola O. The hyperlipidemic hamster as an atherosclerosis model. Artery 1991, 18:285-290.
14. Bocan T.M., Mueller S.B., Mazur M.J., Uhlendorf P.D., Brown E.Q., Kieft K.A. The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation. Atherosclerosis 1993, 102:9-22.
15. Badimon J.J., Badimon L., Galvez A., Dische R., Fuster V. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab Invest 1989, 60:455-461.
16. Badimon J.J., Badimon L., Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest 1990, 85:1234-1241.
17. Worthley S.G., Helft G., Fuster V., Zaman A.G., Fayad Z.A., Fallon J.T., et al. Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation 2000, 101:586-589.
18. Helft G., Worthley S.G., Fuster V., Zaman A.G., Schechter C., Osende J.I., et al. Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. J Am Coll Cardiol 2001, 37:1149-1154.
19. Helft G., Worthley S.G., Fuster V., Fayad Z.A., Zaman A.G., Corti R., et al. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation 2002, 105:993-998.
20. Worthley S.G., Helft G., Fuster V., Fayad Z.A., Shinnar M., Minkoff L.A., et al. A novel nonobstructive intravascular MRI coil: in vivo imaging of experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2003, 23:346-350.
21. Corti R., Osende J.I., Fallon J.T., Fuster V., Mizsei G., Jneid H., et al. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging. J Am Coll Cardiol 2004, 43:464-473.
22. Viles-Gonzalez J.F., Fuster V., Badimon J.J. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 2004, 25:1197-1207.
23. Viles-Gonzalez J.F., Fuster V., Corti R., Valdiviezo C., Hutter R., Corda S., et al. Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition-a magnetic resonance imaging study. Eur Heart J 2005, 26:1557-1561.
24. Corti R., Osende J., Hutter R., Viles-Gonzalez J.F., Zafar U., Valdivieso C., et al. Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI. Atherosclerosis 2007, 190:106-113.
25. Choi B.G., Vilahur G., Cardoso L., Fritton J.C., Ibanez B., Zafar M.U., et al. Ovariectomy increases vascular calcification via the OPG/RANKL cytokine signalling pathway. Eur J Clin Invest 2008, 38:211-217.
26. Choi B.G., Vilahur G., Zafar M.U., Cardoso L., Yadegar D., Ibanez B., et al. Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model. Atherosclerosis 2008, 201:76-84.
27. Ibanez B., Vilahur G., Cimmino G., Speidl W.S., Pinero A., Choi B.G., et al. Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. J Am Coll Cardiol 2008, 51:1104-1109.
28. Ibanez B., Cimmino G., Benezet-Mazuecos J., Santos-Gallego C.G., Pinero A., Prat-Gonzalez S., et al. Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis. Atherosclerosis 2009, 202:185-191.
29. Giannarelli C., Cimmino G., Connolly T.M., Ibanez B., Garcia Ruiz J.M., Alique M., et al. Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis. Eur Heart J 2012, 33:264-273.
30. Aikawa M., Rabkin E., Okada Y., Voglic S.J., Clinton S.K., Brinckerhoff C.E., et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998, 97:2433-2444.
31. Aikawa M., Rabkin E., Voglic S.J., Shing H., Nagai R., Schoen F.J., et al. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res 1998, 83:1015-1026.
32. Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis 1980, 36:261-268.
33. Shiomi M., Ito T. The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe. Atherosclerosis 2009, 207:1-7.
34. Shiomi M., Ito T., Shiraishi M., Watanabe Y. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis. Atherosclerosis 1992, 96:43-52.
35. Shiomi M., Ito T., Yamada S., Kawashima S., Fan J. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). Arterioscler Thromb Vasc Biol 2003, 23:1239-1244.
36. Beaty T.H., Prenger V.L., Virgil D.G., Lewis B., Kwiterovich P.O., Bachorik P.S. A genetic model for control of hypertriglyceridemia and apolipoprotein B levels in the Johns Hopkins colony of St. Thomas Hospital rabbits. Genetics 1992, 132:1095-1104.
37. Nordestgaard B.G., Lewis B. Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain. Atherosclerosis 1991, 87:39-46.
38. Kolodgie F.D., Katocs A.S., Largis E.E., Wrenn S.M., Cornhill J.F., Herderick E.E., et al. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arterioscler Thromb Vasc Biol 1996, 16:1454-1464.
39. Gottlieb H., Lalich J.J. The occurrence of arteriosclerosis in the aorta of swine. Am J Pathol 1954, 30:851-855.
40. Granada J.F., Kaluza G.L., Wilensky R.L., Biedermann B.C., Schwartz R.S., Falk E. Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research. EuroIntervention 2009, 5:140-148.
41. Fritz K.E., Daoud A.S., Augustyn J.M., Jarmolych J. Morphological and biochemical differences among grossly-defined types of swine aortic atherosclerotic lesions induced by a combination of injury and atherogenic diet. Exp Mol Pathol 1980, 32:61-72.
42. Hackman A.M., Pond W.G., Mersmann H.J., Wong W.W., Krook L.P., Zhang S. Obese pigs fed a high cholesterol diet from birth to 2 months are less susceptible than lean pigs to atherosclerosis. J Nutr 1996, 126:564-573.
43. Rapacz J., Hasler-Rapacz J., Taylor K.M., Checovich W.J., Attie A.D. Lipoprotein mutations in pigs are associated with elevated plasma cholesterol and atherosclerosis. Science 1986, 234:1573-1577.
44. Hasler-Rapacz J., Ellegren H., Fridolfsson A.K., Kirkpatrick B., Kirk S., Andersson L., et al. Identification of a mutation in the low density lipoprotein receptor gene associated with recessive familial hypercholesterolemia in swine. Am J Med Genet 1998, 76:379-386.
45. Gerrity R.G., Natarajan R., Nadler J.L., Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001, 50:1654-1665.
46. Mohler E.R., Sarov-Blat L., Shi Y., Hamamdzic D., Zalewski A., Macphee C., et al. Site-specific atherogenic gene expression correlates with subsequent variable lesion development in coronary and peripheral vasculature. Arterioscler Thromb Vasc Biol 2008, 28:850-855. 3rd.
47. Wilensky R.L., Shi Y., Mohler E.R.F 3rd, Hamamdzic D., Burgert M.E., Li J., et al. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 2008, 14:1059-1066.
48. Reitman J.S., Mahley R.W., Fry D.L. Yucatan miniature swine as a model for diet-induced atherosclerosis. Atherosclerosis 1982, 43:119-132.
49. Barbeau M.L., Klemp K.F., Guyton J.R., Rogers K.A. Dietary fish oil. Influence on lesion regression in the porcine model of atherosclerosis. Arterioscler Thromb Vasc Biol 1997, 17:688-694.
50. De Smet B.J., Van der Zande J., Van der Helm Y.J., Kuntz R.E., Borst C., Post M.J. The atherosclerotic Yucatan animal model to study the arterial response after balloon angioplasty: the natural history of remodeling. Cardiovasc Res 1998, 39:224-232.
51. Gal D., Rongione A.J., Slovenkai G.A., DeJesus S.T., Lucas A., Fields C.D., et al. Atherosclerotic Yucatan microswine: an animal model with high-grade, fibrocalcific, nonfatty lesions suitable for testing catheter-based interventions. Am Heart J 1990, 119:291-300.
52. Holvoet P., Theilmeier G., Shivalkar B., Flameng W., Collen D. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol 1998, 18:415-422.
53. Mihaylov D., Van Luyn M.J., Rakhorst G. Development of an animal model of selective coronary atherosclerosis. Coron Artery Dis 2000, 11:145-149.
54. Ishii A., Vinuela F., Murayama Y., Yuki I., Nien Y.L., Yeh D.T., et al. Swine model of carotid artery atherosclerosis: experimental induction by surgical partial ligation and dietary hypercholesterolemia. AJNR Am J Neuroradiol 2006, 27:1893-1899.
55. Granada J.F., Moreno P.R., Burke A.P., Schulz D.G., Raizner A.E., Kaluza G.L. Endovascular needle injection of cholesteryl linoleate into the arterial wall produces complex vascular lesions identifiable by intravascular ultrasound: early development in a porcine model of vulnerable plaque. Coron Artery Dis 2005, 16:217-224.
56. Granada J.F., Wallace-Bradley D., Win H.K., Alviar C.L., Builes A., Lev E.I., et al. In vivo plaque characterization using intravascular ultrasound-virtual histology in a porcine model of complex coronary lesions. Arterioscler Thromb Vasc Biol 2007, 27:387-393.
57. Taylor C.B., Cox G.F., Hall-Tylor B.J., Nelson L.G. Atherosclerosis in areas of vascular injury in monkeys with mild hypercholesterolemia. Circulation 1954, 10:613.
58. Taylor C.B., Cox G.E., Yogi N. Fatal myocardial infarction in rhesus monkey with diet-induced hypercholesterolemia. Am J Pathol 1959, 35:674.
59. Scanu A.M., Khalil A., Neven L., Tidore M., Dawson G., Pfaffinger D., et al. Genetically determined hypercholesterolemia in a rhesus monkey family due to a deficiency of the LDL receptor. J Lipid Res 1988, 29:1671-1681.
60. Kusumi Y., Scanu A.M., McGill H.C., Wissler R.W. Atherosclerosis in a rhesus monkey with genetic hypercholesterolemia and elevated plasma Lp(a). Atherosclerosis 1993, 99:165-174.
61. Daugherty A., Whitman S.C. Quantification of atherosclerosis in mice. Methods Mol Biol 2003, 209:293-309.
62. Van Ree J.H., Van den Broek W.J., Dahlmans V.E., Groot P.H., Vidgeon-Hart M., Frants R.R., et al. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis 1994, 111:25-37.
63. Purcell-Huynh D.A., Farese R.V., Johnson D.F., Flynn L.M., Pierotti V., Newland D.L., et al. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J Clin Invest 1995, 95:2246-2257.
64. Lawn R.M., Wade D.P., Hammer R.E., Chiesa G., Verstuyft J.G., Rubin E.M. Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature 1992, 360:670-672.
65. Marotti K.R., Castle C.K., Boyle T.P., Lin A.H., Murray R.W., Melchior G.W. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993, 364:73-75.
66. Fazio S., Sanan D.A., Lee Y.L., Ji Z.S., Mahley R.W., Rall S.C. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112, Cys142). Arterioscler Thromb 1994, 14:1873-1879.
67. Van Vlijmen B.J., Van den Maagdenberg A.M., Gijbels M.J., Van der Boom H., HogenEsch H., Frants R.R., et al. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest 1994, 93:1403-1410.
68. Masucci-Magoulas L., Goldberg I.J., Bisgaier C.L., Serajuddin H., Francone O.L., Breslow J.L., et al. A mouse model with features of familial combined hyperlipidemia. Science 1997, 275:391-394.
69. Powell-Braxton L., Veniant M., Latvala R.D., Hirano K.I., Won W.B., Ross J., et al. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat Med 1998, 4:934-938.
70. Al-Mashhadi R.H., Sorensen C.B., Kragh P.M., Christoffersen C., Mortensen M.B., Tolbod L.P., et al. Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant. Sci Transl Med 2013, 5:166ra1.